Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
To characterize treatment patterns and healthcare resource utilization among adults diagnosed with non-valvular atrial fibrillation (NVAF) from the private setting in Venezuela.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| NVAF Treatment patterns | Treatment patterns will be collected during the follow-up period. Data will be directly extracted from medical charts of the arrhythmia unit. Anticoagulation use will be reported as drug class: Vitamin K antagonist, antiplatelet, nonsteroidal anti-inflammatory drugs. The following data on anticoagulation use will be collected:
|
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Frequency of Hospitalization | approximately 2 years after enrollment | |
| Duration of Hospitalization | approximately 2 years after enrollment | |
| Frequency of Outpatient visits | approximately 2 years after enrollment |
| Measure | Description | Time Frame |
|---|---|---|
| Incidence of Cerebrovascular Disease (CVD) | Up to 3 years | |
| Frequency of Hospitalization due to Cerebrovascular Disease (CVD) | Up to 3 years | |
| Duration of Hospitalization due to Cerebrovascular Disease (CVD) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
This observational, non-interventional, retrospective and longitudinal study of NVAF patients in the private sector in Venezuela based on two study samples to be analyzed separately, medical chart review and an electronic database analysis
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Bristol-Myers Squibb | Bristol-Myers Squibb | Study Director |
Not provided
Not provided
Not provided
Not provided
Not provided
| Up to 3 years |
| Frequency of Outpatient Visits due to Cerebrovascular Disease (CVD) | Up to 3 years |
| Incidence of Acute Myocardial Infarction (AMI) | Up to 3 years |
| Frequency of Hospitalization due to Acute Myocardial Infarction (AMI) | Up to 3 years |
| Duration of Hospitalization due to Acute Myocardial Infarction (AMI) | Up to 3 years |
| Frequency of Outpatient Visits due to Acute Myocardial Infarction (AMI) | Up to 3 years |
| Incidence of Systemic Embolism (SE) | Up to 3 years |
| Frequency of Hospitalization due to Systemic Embolism (SE) | Up to 3 years |
| Duration of Hospitalization due to Systemic Embolism (SE) | Up to 3 years |
| Frequency of Outpatient Visits due to Systemic Embolism (SE) | Up to 3 years |
| Incidence of Gastrointestinal Hemorrhage (GIH) | Up to 3 years |
| Frequency of Hospitalization due to Gastrointestinal Hemorrhage (GIH) | Up to 3 years |
| Duration of Hospitalization due to Gastrointestinal Hemorrhage (GIH) | Up to 3 years |
| Frequency of Outpatient Visits due to Gastrointestinal Hemorrhage (GIH) | Up to 3 years |